Rizatriptan

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome PastilleOR 95%CII2k No. casesNo. exposedpublication biasROB???
All congenital malformations (majors, minors, majors and minors, or unspecified)insufficient precision0.83 [0.48, 1.43]0%2 studies56,797467not evaluable NApptx
Major congenital malformationsinsufficient precision0.72 [0.31, 1.69]-1 study22310not evaluable NApptx

Growth parameters and prematurity
Adverse outcome PastilleOR 95%CII2k No. casesNo. exposedpublication biasROB???
Low birth weight (< 2500g)insufficient precision0.75 [0.37, 1.52]-1 study33334not evaluable NApptx
Preterm (< 37 weeks)no evidence of harm0.48 [0.26, 0.88]-1 study47334not evaluable NApptx
Small for gestational age (weight)insufficient precision1.19 [0.69, 2.03]-1 study61334not evaluable NApptx

Maternal consequences
Adverse outcome PastilleOR 95%CII2k No. casesNo. exposedpublication biasROB???
Postpartum hemorrhageno data1.11 [0.40, 3.08]-1 study5326not evaluable NApptx

Neonatal disorders
Adverse outcome PastilleOR 95%CII2k No. casesNo. exposedpublication biasROB???
Neonatal medical careno data1.58 [0.51, 4.91]-1 study3226not evaluable NApptx

Hide endpoints reported in only one study ...